Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.980
+0.013 (1.38%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Heron Therapeutics Employees
Heron Therapeutics had 128 employees as of December 31, 2025. The number of employees increased by 6 or 4.92% compared to the previous year.
Employees
128
Change (1Y)
6
Growth (1Y)
4.92%
Revenue / Employee
$1,210,188
Profits / Employee
-$157,773
Market Cap
184.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 166 |
| Molecular Partners AG | 153 |
| Nkarta | 105 |
| Vaxart | 105 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
| Whitehawk Therapeutics | 22 |
| Sagimet Biosciences | 14 |
HRTX News
- 10 days ago - Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 19 days ago - Heron: Near The Bottom Of A Trading Range Despite Positives - Seeking Alpha
- 20 days ago - Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - GlobeNewsWire
- 2 months ago - Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - GlobeNewsWire
- 3 months ago - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) - GlobeNewsWire
- 4 months ago - Heron Therapeutics, Inc. (HRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress - GlobeNewsWire